ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Osiris Therape (MM)

Osiris Therape (MM) (OSIR)

18.99
0.00
(0.00%)
Closed March 27 04:00PM
18.99
0.00
( 0.00% )
Pre Market: 08:00PM

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

OSIR News

Official News Only

OSIR Discussion

View Posts
tedkov tedkov 5 years ago
Osiris Shareholders Upset Over Merger Bid - (via Business Journal)
March 12, 2019
Tags: NewsPoints Osiris Smith & Nephew United States Corporate Affairs Mergers &
Acquisitions

A group of Osiris Therapeutics Inc. shareholders are attempting
to block the $660.5 million purchase of the company by Smith & Nephew plc.

The shareholders allege that the purchase price of $19 per share is insufficient in light of the company's growth prospects, and that deal-protection clauses in the merger agreement preclude other
companies from submitting successful competing offers. In addition, shareholders allege that Osiris senior management obtained personal benefits for their own self interests in agreeing to sell the company that are not being shared with common stockholders.

Osiris Therapeutics did not immediately respond to requests for a comment.
To contact the law firm on behalf of shareholders of
Osiris Therapeutics for more information as to how you can participate with other shareholders for a higher price at no cost or expense call toll free 800.511.7037 or contact@tripplevy.com
👍️0
spsiege spsiege 5 years ago
The Street raised OSIR to Buy with a target of $19.10
👍️0
Renee Renee 6 years ago
OSIR moved from the OTC to the Nasdaq:

http://otce.finra.org/DLDeletions
👍️0
sabadollar sabadollar 6 years ago
Next week will be the last chance to buy under 10$! Will buy more on Monday ??
👍️0
Logon26 Logon26 6 years ago
Bye Bye OTC - 10-K out
👍️0
Logon26 Logon26 6 years ago
The Company currently expects that it will file the comprehensive Form 10-K filing no later than March 28, 2018.
👍️0
sabadollar sabadollar 6 years ago
Osir buy 8,6 - expecting financials this or next week! $MESO - share price up! also good for OSIR.
👍️0
stocktrademan stocktrademan 6 years ago
OSIR buy 5.720

bull flag
inverted head and shoulders bottom
bullish divergence
support at moving averages
previous high volume indicates the bottom and major support
because most of all the potential sellers are now exhausted and out
price now beginning a nascent uptrend above the ichimoku span clouds

















normal chart




log chart



👍️0
Renee Renee 6 years ago
OSIR: SEC charges Biotech Company, Executives with accounting fraud:

https://www.sec.gov/litigation/litreleases/2017/lr23978.htm
👍️0
stocktrademan stocktrademan 7 years ago
OSIR bullish 2.80









normal chart




log chart



👍️0
Renee Renee 7 years ago
OSIR delisted from the Nasdaq to the OTC:

http://otce.finra.org/DLAdditions
👍️0
willlbone willlbone 7 years ago
Delisting from NASDAQ
👍️0
spsiege spsiege 7 years ago
http://www.businesswire.com/news/home/20161215006156/en/Whistleblowers-Claim-MiMedx-Group-Defrauded-Investors-Lawsuit
👍️0
3ch0 3ch0 7 years ago
Staying on NASDAQ :) $OSIR
👍️0
3ch0 3ch0 7 years ago
Nice news. $OSIR
👍️0
3ch0 3ch0 7 years ago
Interesting week ahead. $OSIR
👍️0
3ch0 3ch0 7 years ago
I do not draw confidence nor base any trade in any market/exchange off those sources. Its not behove Imo.
👍️0
3ch0 3ch0 7 years ago
Consolidation $OSIR
👍️0
Randle Clint Randle Clint 7 years ago
Found on the StockTwits board, "Osiris Therapeutics: Regenerative Technologies And Restated Financials seekingalpha.com/article/40... $OSIR Dump is coming, sell before the dump! Bearish".

Article showing a lot of current issues, including active investigations? and concerns about financial statements...
👍️0
3ch0 3ch0 7 years ago
Fantastic moves $OSIR
👍️0
Randle Clint Randle Clint 7 years ago
New to this board, and wondering who can point to good DD for their recovery plan after disclosures this year. Thanks!
👍️0
ClayTrader ClayTrader 7 years ago
* * $OSIR Video Chart 11-08-16 * *

Link to Video - click here to watch the technical chart video
👍️0
3ch0 3ch0 8 years ago
Settled higher base. OSIR
👍️0
3ch0 3ch0 8 years ago
Volatility has brought opportunity. Green trend still Long , We will see. OSIR
👍️0
3ch0 3ch0 8 years ago
Not the confidence building move.
👍️0
spsiege spsiege 8 years ago
Well, Sept 12 has come and in a few hours went. Now what?
👍️0
3ch0 3ch0 8 years ago
Almost time for update as well.
👍️0
3ch0 3ch0 8 years ago
Yes, a good idea. Wonderful setup these past 3 months no ?
A close above 5.60 at the least
👍️0
spsiege spsiege 8 years ago
Any idea what might happen Monday?
👍️0
3ch0 3ch0 8 years ago
Superior Day Osiris! Strong Green Trend Confirmation. $OSIR
👍️0
3ch0 3ch0 8 years ago
A line of research I have been particularly interested in/following will be very fruitful soon as it is Understood. OSIR
👍️0
3ch0 3ch0 8 years ago
The Potential for Osiris is Great.
Like the research and product applications.
Impacts many Lives Positively. Room for Growth.
Followed a long Time , Undervalued Greatly but unfortunate with last year but left a wide door for Opportunity.
The Trend is Green , Confidence Stronger

$OSIR
👍️0
BananaApes BananaApes 8 years ago
Osiris Therapeutics Profiled

Stem Cells Market About Therapeutic Benefits Boosts Value of US$119.5 bn in 2018

September 1st, 2016
http://www.medgadget.com/2016/09/stem-cells-market-about-therapeutic-benefits-boosts-value-of-us119-5-bn-in-2018.html

Global Stem Cells Market to Reach US $119.5 Bn by 2018, Rising Awareness About Therapeutic Benefits Boosts Popularity

Published: August 19th, 2016
http://www.sbwire.com/press-releases/stem-cells-market/release-716200.htm?utm_source=djournal&utm_medium=feed&utm_campaign=distribution

Also, "Some of the key enterprises operating in the global stem cells market, namely,...have been profiled in this study."

U.S. Stem Cell / BioHeart Profiled
Symbol: USRM
Shares Outstanding: 14.45M
Float: 12.17M
Stock Price: $0.02

A diamond in the rough or a 100 pound gold nugget?
👍️0
3ch0 3ch0 8 years ago
Looking good. OSIR
👍️0
3ch0 3ch0 8 years ago
Looking slick but long term trend still Green.
👍️0
3ch0 3ch0 8 years ago
Are we Breaking Uptrend OSIR?
👍️0
3ch0 3ch0 8 years ago
Trend Continues.
Strong Green Close Tomorrow
Starting to prime. $OSIR
👍️0
3ch0 3ch0 8 years ago
Looking good for tommrow. OSIR
👍️0
3ch0 3ch0 8 years ago
Nice pull - Confidence Building
👍️0
3ch0 3ch0 8 years ago
Nice Day , Like what I see
Trend Observed

👍️0
JefftDecker JefftDecker 8 years ago
OSIR


where to next? maybe slight pullback to accumulate?

R5
👍️0
JefftDecker JefftDecker 8 years ago
OSIR


where to next? maybe slight pullback to accumulate?

R5
👍️0
JefftDecker JefftDecker 8 years ago
OSIR

running under the radar screen im guessing.

R5
👍️0
JefftDecker JefftDecker 8 years ago
OSIR

hate gaps up but whatta we gonna do, didnt get as many as i wanted
but happy for now.

Happy Coding
R5
👍️0
spsiege spsiege 8 years ago
August 4 2016
Grafix(R) Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds with Exposed Tendon and Bone Clinical Trial is Available Electronically in Peer-Reviewed Journal

COLUMBIA, Md. , Aug. 04, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that the manuscript from its multicenter prospective post-market clinical trial using Grafix was accepted for publication in the International Wound Journal , is now available online and will appear in an upcoming issue of the journal.
About the Trial (Protocol 310)
Patients between 18 and 85 years of age with confirmed type 1 or type 2 diabetes and with chronic complex diabetic foot wounds that extended through the dermis and into the subcutaneous tissue with evidence of exposed muscle, tendon, bone, and/or joint capsule were considered for this study. Ulcers had to be able to accommodate up to three 5 cm x 5 cm pieces of Grafix. Patients were excluded from the trial if the ulcer had any evidence of active infection at screening. Patients received treatment with Grafix weekly for up to 16 weeks. The primary endpoint measured 100% granulation of wound by 16 weeks as determined by the investigator. Secondary endpoints included complete wound closure rates, time to 100% granulation, number of applications, and percent wound area reduction at 4 weeks, 8 weeks, 12 weeks, and 16 weeks. 31 patients were enrolled, and 27 completed the study. The patient group had significant co-morbidity, with over 80% having hypertension, over 60% being current or former smokers, 55% having heart disease and 45% having had a previous partial amputation. The mean wound area was 14.6 cm2 with mean duration of 7.5 months, and 67.7% of patients failed advanced wound therapies prior to Grafix. For patients completing the protocol, the primary endpoint, 100% wound granulation by week 16, was met by 96.3% of patients in a mean of 6.8 weeks. Complete wound closure occurred in 59.3% (mean 9.1 weeks). Osiris Therapeutics partnered with CPC Clinical Research , an Academic Clinical Research Organization (CRO), who was responsible for data management and pharmacovigilance services. The protocol was submitted to clinicaltrials.gov (Reference # NCT02260609).
About Grafix®
👍️0
JefftDecker JefftDecker 8 years ago
OSIR- News

small trades after hours at $5.77 tomorrow should be interesting

R5
👍️0
JefftDecker JefftDecker 8 years ago
OSIR

Osiris actually headed up to some important pivot points and resistance zones on strength, with about 17% of the float shorted and a short ratio of 32.29, this could turn into a short squeeze fast should it keep trickling up. I'll be watching the action and dabbling for a few more just in case, Ill be cautious where to set a trailing stop just in case, these algorithms are a bitch sometimes to figure out. more later. trade well

Happy coding
R5
👍️0
3ch0 3ch0 8 years ago
I agree. Have had eyes on OSIR for a while as well.
👍️0
JefftDecker JefftDecker 8 years ago
OSIR


dead duck bounce

R5
👍️0
JefftDecker JefftDecker 8 years ago
OSIR

been stalking this for sometime, starting to look ready to go up
started a small position and will build going up should that happen,
Biotechs seem to be staying strong for now.

R5
👍️0

Your Recent History

Delayed Upgrade Clock